Imaging Dynamics
CVE:IDLImaging Dynamics Company Ltd., a medical technology company, manufactures and sells medical imaging devices in the Americas and internationally. The company researches and develops digital radiography (DR) equipment, including medical charge coupled device (CCD) detectors, medical flat panel detectors, multifunction X-ray machines, and veterinary X-ray machines. It also offers imaging detectors; flat panel detectors under Aquarius 8600 and VetnovaXion names; Magellan, a medical image processing software; and Sirius, a veterinary image processing software. In addition, the company provides 1600 Plus X-Series, a DR solution with a floor mounted U-arm multi-axis positioning device that includes X-ray tube, collimator, and generator; and veterinary DR systems. It offers products through dealers, distributors, and original equipment manufacturer partners. The company was formerly known as Imaging Dynamics Corporation and changed its name to Imaging Dynamics Company Ltd. in October 2001. Imaging Dynamics Company Ltd. was incorporated in 1995 and is headquartered in Toronto, Canada.
Global X Silver Miners ETF
NYSEARCA:SILThe Global X Silver Miners ETF (SIL) is an exchange-traded fund that mostly invests in materials equity. The fund tracks a market-cap-weighted index of companies actively engaged in the silver mining industry. SIL was launched on Apr 19, 2010 and is managed by Global X.
VentriPoint Diagnostics
CVE:VPTVentripoint Diagnostics Ltd., a medical device company, engages in the development and commercialization of diagnostic tools that monitor patients with heart disease worldwide. The company offers Ventripoint Medical System (VMS), a medical imaging system that is used to generate three-dimensional models with critical volume and functional measurements of a patient's heart chambers; VMS+ software for use in creating three-dimensional model that generates accurate heart volumetric measurements. It also develops a suite of applications for various heart diseases and imaging modalities, including congenital heart disease, pulmonary hypertension, cardiotoxicity of chemotherapy treatments for cancer, and Covid-19 related heart issues. The company was incorporated in 2005 and is headquartered in Toronto, Canada.
